Phase 3 ENDEAR study in infants with SMA enrolling; on track to initiate Phase 3 study in children with SMA later this year Isis to host a webcast at 11:30 a.m. EDT on Friday, October 10
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin Data published in New England Journal of Medicine and featured at the American Society of Hematology annual meeting
Isis to host a webcast at 9:00 a.m. ET on Monday, December 8, 2014 CARLSBAD, Calif.
Substantial reductions of up to 86% in triglycerides observed All patients achieved a triglyceride level First study to support the role of apoC-III as a key regulator of triglyceride metabolism utilizing multiple pathways
BAGHDAD--Islamic State group militants shot down an Iraqi military helicopter, officials said Saturday, killing the two pilots on board and raising fresh concerns about the extremists' ability to attack aircraft amid ongoing U.S.-led coalition airstrikes.
TEL AVIV, Israel , November 25, 2014 /PRNewswire/ --
ILCO announces shareholders' meeting to be held on December 31st to approve the proposed separation of its holdings, and publishes full transaction report detailing the process and proposed new structure ILCO's new strategic focus following the separation will be on its remaining public holdings, Israel Chemicals (NYSE:ICL, TASE:ICL) and Bazan (TASE:ORL), and it will refrain from investing in new companies.
Starboard is Extremely Gratified that the Two Leading Independent Proxy Voting Advisory Firms Have Recommended Darden Shareholders Vote for All Twelve of Starboard's World-Class Nominees on Starboard's WHITE Proxy Card
ISS Concludes that "Significant Board Change Is Warranted" and Glass Lewis States that the Election of all Twelve of Starboard's Nominees "Is More Likely to Effect Long-Term Improvements and Provide Greater Board Oversight" at Darden ISS States that Starboard's Entire Director Slate "Is Endowed with an Embarrassment of Riches" and Glass Lewis Finds Starboard's Twelve Supremely Qualified Nominees to be "Far More Compelling" and "Significantly Better-Suited" than Darden's Proposed Nominees Corporate Governance Research Firm, Proxy Mosaic, Has Also Now Recommended for All Twelve of Starboard's Nominees for Darden Starboard Urges All Shareholders to Follow the Lead of ISS, Glass Lewis, and Proxy Mosaic and Vote the WHITE Proxy Card to Support the
Concludes that "Significant Board Change Is Warranted" and Recommends Darden Shareholders Vote to Elect All Twelve of Starboard's Nominees at Upcoming Annual Meeting on Starboard's WHITE Proxy Card
States that Starboard Has Assembled a "Compelling Slate with Extensive, Deep, and Relevant Experience" that "Is Endowed with an Embarrassment of Riches" Finds that Starboard Has Provided a "More Thoughtful Solution to Board Continuity" Starboard is Extremely Gratified by the Resounding Show of Support From the Two Leading Independent Proxy Voting Advisory Firms in Recommending for the Election of Starboard's Entire Slate of World-Class Nominees Starboard Urges All Shareholders to Follow the Lead of ISS and Glass Lewis and Vote the WHITE Proxy Card to Support the Election of All Twelve of Starboard's Highly Qualified Nominees NEW YORK , Sept.
Clover Partners, the general partner of MHC Mutual Conversion Fund,
L.P., is pleased to announce that Institutional Shareholder Services
Inc. ("ISS"), an influential and leading proxy advisory firm, has chosen
to support both Mr.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.